Insulet (PODD) Tops Q2 EPS by 21c
Insulet (NASDAQ: PODD) reported Q2 EPS of $1.66, $0.21 better than the analyst estimate of $1.45. Revenue for the quarter came in at $801.7 million versus the consensus estimate of $787.82 million.
Raises adjusted EPS growth guidance from >25% to >30%. Cuts FY revenue outlook growth from 21-23% to 20-22%.
For earnings history and earnings-related data on Insulet (PODD) click here.